3,137 research outputs found
Angoff anchor statements: setting a flawed gold standard?
http://www.mededpublish.org/manuscripts/120
Systematic review of the health-related quality of life issues facing adolescents and young adults with cancer
PURPOSE: For adolescents and young adults (AYAs), the impact of a cancer diagnosis and subsequent treatment is likely to be distinct from other age groups given the unique and complex psychosocial challenges of this developmental phase. In this review of the literature, we report the health-related quality of life (HRQoL) issues experienced by AYAs diagnosed with cancer and undergoing treatment.
METHODS: MEDLINE, EMBASE, CINAHL, PsychINFO and the Cochrane Library Databases were searched for publications reporting HRQoL of AYAs. Issues generated from interviews with AYAs or from responses to patient reported outcome measures (PROMs) were extracted.
RESULTS: 166 papers were reviewed in full and comprised 72 papers covering 69 primary studies, 49 measurement development or evaluation papers and 45 reviews. Of the 69 studies reviewed, 11 (16%) used interviews to elicit AYAs’ descriptions of HRQoL issues. The majority of the PROMs used in the studies represent adaptations of paediatric or adult measures. HRQoL issues were organised into the following categories: physical, cognitive, restricted activities, relationships with others, fertility, emotions, body image and spirituality/outlook on life.
CONCLUSION: The HRQoL issues presented within this review are likely to be informative to health care professionals and AYAs. The extensive list of issues suggests that the impact of a cancer diagnosis and treatment during adolescence and young adulthood is widespread and reflects the complexities of this developmental phase
Therapeutic DNA vaccine induces broad T cell responses in the gut and sustained protection from viral rebound and AIDS in SIV-infected rhesus macaques.
Immunotherapies that induce durable immune control of chronic HIV infection may eliminate the need for life-long dependence on drugs. We investigated a DNA vaccine formulated with a novel genetic adjuvant that stimulates immune responses in the blood and gut for the ability to improve therapy in rhesus macaques chronically infected with SIV. Using the SIV-macaque model for AIDS, we show that epidermal co-delivery of plasmids expressing SIV Gag, RT, Nef and Env, and the mucosal adjuvant, heat-labile E. coli enterotoxin (LT), during antiretroviral therapy (ART) induced a substantial 2-4-log fold reduction in mean virus burden in both the gut and blood when compared to unvaccinated controls and provided durable protection from viral rebound and disease progression after the drug was discontinued. This effect was associated with significant increases in IFN-γ T cell responses in both the blood and gut and SIV-specific CD8+ T cells with dual TNF-α and cytolytic effector functions in the blood. Importantly, a broader specificity in the T cell response seen in the gut, but not the blood, significantly correlated with a reduction in virus production in mucosal tissues and a lower virus burden in plasma. We conclude that immunizing with vaccines that induce immune responses in mucosal gut tissue could reduce residual viral reservoirs during drug therapy and improve long-term treatment of HIV infection in humans
Optical Magnetometry
Some of the most sensitive methods of measuring magnetic fields utilize
interactions of resonant light with atomic vapor. Recent developments in this
vibrant field are improving magnetometers in many traditional areas such as
measurement of geomagnetic anomalies and magnetic fields in space, and are
opening the door to new ones, including, dynamical measurements of bio-magnetic
fields, detection of nuclear magnetic resonance (NMR), magnetic-resonance
imaging (MRI), inertial-rotation sensing, magnetic microscopy with cold atoms,
and tests of fundamental symmetries of Nature.Comment: 11 pages; 4 figures; submitted to Nature Physic
Photometric redshift accuracy in AKARI Deep Surveys
We investigate the photometric redshift accuracy achievable with the AKARI
infrared data in deep multi-band surveys, such as in the North Ecliptic Pole
field. We demonstrate that the passage of redshifted policyclic aromatic
hydrocarbons and silicate features into the mid-infrared wavelength window
covered by AKARI is a valuable means to recover the redshifts of starburst
galaxies. To this end we have collected a sample of ~60 galaxies drawn from the
GOODS-North Field with spectroscopic redshift 0.5<~z_spec<~1.5 and photometry
from 3.6 to 24 micron, provided by the Spitzer, ISO and AKARI satellites. The
infrared spectra are fitted using synthetic galaxy Spectral Energy
Distributions which account for starburst and active nuclei emission. For ~90%
of the sources in our sample the redshift is recovered with an accuracy
|z_phot-z_spec|/(1+z_spec)<~10%. A similar analysis performed on different sets
of simulated spectra shows that the AKARI infrared data alone can provide
photometric redshifts accurate to |z_phot-z_spec|/(1+z_spec)<~10% (1-sigma) at
z<~2. At higher redshifts the PAH features are shifted outside the wavelength
range covered by AKARI and the photo-z estimates rely on the less prominent 1.6
micron stellar bump; the accuracy achievable in this case on (1+z) is ~10-15%,
provided that the AGN contribution to the infrared emission is subdominant. Our
technique is no more prone to redshift aliasing than optical-uv photo-z, and it
may be possible to reduce this aliasing further with the addition of
submillimetre and/or radio data.Comment: 27 pages, 12 figures, 4 tables. Accepted for publication on MNRA
The Hydration Structure at Yttria-Stabilized Cubic Zirconia (110)-Water Interface with Sub-Angstrom Resolution
The interfacial hydration structure of yttria-stabilized cubic zirconia (110) surface in contact with water was determined with ~0.5&#8201;&Aring; resolution by high-resolution X-ray reflectivity measurement. The terminal layer shows a reduced electron density compared to the following substrate lattice layers, which indicates there are additional defects generated by metal depletion as well as intrinsic oxygen vacancies, both of which are apparently filled by water species. Above this top surface layer, two additional adsorbed layers are observed forming a characteristic interfacial hydration structure. The first adsorbed layer shows abnormally high density as pure water and likely includes metal species, whereas the second layer consists of pure water. The observed interfacial hydration structure seems responsible for local equilibration of the defective surface in water and eventually regulating the long-term degradation processes. The multitude of water interactions with the zirconia surface results in the complex but highly ordered interfacial structure constituting the reaction front.ope
A systematic review of randomised controlled trials on the effectiveness of exercise programs on lumbo pelvic pain among postnatal women
Background: A substantial number of women tend to be affected by Lumbo Pelvic Pain (LPP) following child birth.
Physical exercise is indicated as a beneficial method to relieve LPP, but individual studies appear to suggest mixed
findings about its effectiveness. This systematic review aimed to synthesise evidence from randomised controlled trials on the effectiveness of exercise on LPP among postnatal women to inform policy, practice and future research.
Methods: A systematic review was conducted of all randomised controlled trials published between January 1990 and July 2014, identified through a comprehensive search of following databases: PubMed, PEDro, Embase, Cinahl, Medline, SPORTDiscus, Cochrane Pregnancy and Childbirth Group’s Trials Register, and electronic libraries of authors’institutions.
Randomised controlled trials were eligible for inclusion if the intervention comprised of postnatal exercise for women
with LPP onset during pregnancy or within 3 months after delivery and the outcome measures included changes in
LPP. Selected articles were assessed using the PEDro Scale for methodological quality and findings were synthesised narratively as meta-analysis was found to be inappropriate due to heterogeneity among included studies.
Results: Four randomised controlled trials were included, involving 251 postnatal women. Three trials were rated as
of ‘good’ methodological quality. All trials, except one, were at low risk of bias. The trials included physical exercise
programs with varying components, differing modes of delivery, follow up times and outcome measures. Intervention
in one trial, involving physical therapy with specific stabilising exercises, proved to be effective in reducing LPP
intensity. An improvement in gluteal pain on the right side was reported in another trial and a significant difference in
pain frequency in another.
Conclusion: Our review indicates that only few randomised controlled trials have evaluated the effectiveness of
exercise on LPP among postnatal women. There is also a great amount of variability across existing trials in the
components of exercise programs, modes of delivery, follow up times and outcome measures. While there is some
evidence to indicate the effectiveness of exercise for relieving LPP, further good quality trials are needed to ascertain
the most effective elements of postnatal exercise programs suited for LPP treatment
Cognitive function in a randomized trial of evolocumab
Inga Stuķēna as well as a complete list of investigators is provided in the Supplementary Appendix, available at NEJM.org. https://www.nejm.org/doi/suppl/10.1056/NEJMoa1701131/suppl_file/nejmoa1701131_appendix.pdf Funding Information: (Funded by Amgen; EBBINGHAUS ClinicalTrials.gov number, NCT02207634.) Supported by Amgen. We thank Sarah T. Farias, Ph.D., at UC Davis Health for providing the English-language and translated versions of the Everyday Cognition (ECog) tool. Publisher Copyright: Copyright © 2017 Massachusetts Medical Society.BACKGROUND: Findings from clinical trials of proprotein convertase subtilisin–kexin type 9 (PCSK9) inhibitors have led to concern that these drugs or the low levels of low-density lipoprotein (LDL) cholesterol that result from their use are associated with cognitive deficits. METHODS: In a subgroup of patients from a randomized, placebo-controlled trial of evolocumab added to statin therapy, we prospectively assessed cognitive function using the Cambridge Neuropsychological Test Automated Battery. The primary end point was the score on the spatial working memory strategy index of executive function (scores range from 4 to 28, with lower scores indicating a more efficient use of strategy and planning). Secondary end points were the scores for working memory (scores range from 0 to 279, with lower scores indicating fewer errors), episodic memory (scores range from 0 to 70, with lower scores indicating fewer errors), and psychomotor speed (scores range from 100 to 5100 msec, with faster times representing better performance). Assessments of cognitive function were performed at baseline, week 24, yearly, and at the end of the trial. The primary analysis was a noninferiority comparison of the mean change from baseline in the score on the spatial working memory strategy index of executive function between the patients who received evolocumab and those who received placebo; the noninferiority margin was set at 20% of the standard deviation of the score in the placebo group. RESULTS: A total of 1204 patients were followed for a median of 19 months; the mean (±SD) change from baseline over time in the raw score for the spatial working memory strategy index of executive function (primary end point) was −0.21±2.62 in the evolocumab group and −0.29±2.81 in the placebo group (P<0.001 for noninferiority; P=0.85 for superiority). There were no significant between-group differences in the secondary end points of scores for working memory (change in raw score, −0.52 in the evolocumab group and −0.93 in the placebo group), episodic memory (change in raw score, −1.53 and −1.53, respectively), or psychomotor speed (change in raw score, 5.2 msec and 0.9 msec, respectively). In an exploratory analysis, there were no associations between LDL cholesterol levels and cognitive changes. CONCLUSIONS: In a randomized trial involving patients who received either evolocumab or placebo in addition to statin therapy, no significant between-group difference in cognitive function was observed over a median of 19 months.publishersversionPeer reviewe
Get screened: a pragmatic randomized controlled trial to increase mammography and colorectal cancer screening in a large, safety net practice
Abstract Background Most randomized controlled trials of interventions designed to promote cancer screening, particularly those targeting poor and minority patients, enroll selected patients. Relatively little is known about the benefits of these interventions among unselected patients. Methods/Design "Get Screened" is an American Cancer Society-sponsored randomized controlled trial designed to promote mammography and colorectal cancer screening in a primary care practice serving low-income patients. Eligible patients who are past due for mammography or colorectal cancer screening are entered into a tracking registry and randomly assigned to early or delayed intervention. This 6-month intervention is multimodal, involving patient prompts, clinician prompts, and outreach. At the time of the patient visit, eligible patients receive a low-literacy patient education tool. At the same time, clinicians receive a prompt to remind them to order the test and, when appropriate, a tool designed to simplify colorectal cancer screening decision-making. Patient outreach consists of personalized letters, automated telephone reminders, assistance with scheduling, and linkage of uninsured patients to the local National Breast and Cervical Cancer Early Detection program. Interventions are repeated for patients who fail to respond to early interventions. We will compare rates of screening between randomized groups, as well as planned secondary analyses of minority patients and uninsured patients. Data from the pilot phase show that this multimodal intervention triples rates of cancer screening (adjusted odds ratio 3.63; 95% CI 2.35 - 5.61). Discussion This study protocol is designed to assess a multimodal approach to promotion of breast and colorectal cancer screening among underserved patients. We hypothesize that a multimodal approach will significantly improve cancer screening rates. The trial was registered at Clinical Trials.gov NCT00818857http://deepblue.lib.umich.edu/bitstream/2027.42/78264/1/1472-6963-10-280.xmlhttp://deepblue.lib.umich.edu/bitstream/2027.42/78264/2/1472-6963-10-280.pdfPeer Reviewe
The Bright Ages Survey. I. Imaging Data
This is the first paper in a series presenting and analyzing data for a
K-selected sample of galaxies collected in order to identify and study galaxies
at moderate to high redshift in rest-wavelength optical light. The sample
contains 842 objects over 6 separate fields covering 75.6 arcmin^2 down to
K=20-20.5. We combine the K-band with UBVRIzJH multi-band imaging, reaching
depths of R~26. Two of the fields studied also have deep HST WFPC2 imaging,
totaling more than 60 hours in the F300W, F450W, F606W, and F814W filters.
Using artificial galaxy modeling and extraction we measure 85% completeness
limits down to K=19.5-20, depending on the field examined. The derived K-band
number counts are in good agreement with previous studies. We find a density
for Extremely Red Objects(EROs; R-K>5) of 1.55+/-0.16 arcmin^{-2} for K<19.7,
dominated by the 1714+5015 field (centered on 53w002), with an ERO number
density more than 3 times that of the other sample fields. If we exclude the
counts for 1714+5015, our density is 0.95+/- 0.14 arcmin. Both ERO densities
are consistent with previous measurements due to the significant known cosmic
variance of these red sources.Keck spectroscopic redshifts were obtained for 18
of the EROs, all but one of which are emission galaxies. None of the EROs in
the 1714+5015 field for which we obtained spectroscopic redshifts are
associated with the known z=2.39 over-density, although there are three
different galaxy redshift pairs (z=0.90, z=1.03, z=1.22).Comment: 30 pages, 5 figures, accepted by Ap
- …